REGRANEX Pages on BioPortfolio:

BioPortfolio - Regranex
Regranex - BioPortfolio - Indepth. ... SOMERVILLE, N.J., June 6 /PRNewswire/ -- ETHICON, INC. today announces revised labeling for REGRANEX Gel, ...
http://www.bioportfolio.com/indepth/Regranex.html...

BioPortfolio Limited Worldwide Wound Management, 2007-2016 ...
3.10.2.4 Regranex 3.10.2.5 Other Growth Factors 3.10.2.6 Non-Growth Factor Modulators 3.10.3 Market and Competitive Analysis 3.10.3.1 Growth Factors ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_307.html...

BioPortfolio.com - BioWeb PROSTASCINT CAPROMAB PENDETIDE Search
... Inc Asparaginase Elspar Merck & Co., Inc Basiliximab Simulect Novartis Pharmaceuticals Corp Becaplermin Regranex OMJ Pharmaceuticals, Inc Becaplermin
...
http://www.bioportfolio.co.uk/PROSTASCINT+CAPROMAB+PENDETIDE...

BioPortfolio Limited Diabetes Market Forecast to 2013 (TA221)
Regranex * Lucentis * Atacand * Epicept NP-1 * Qnexa PRODUCT PROFILE COMPONENTS * Drug's development and approval history ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_742.html...

Results from other life science and pharmaceutical sites:

Communication about an Ongoing Safety Review of Regranex (becaplermin)
10 Jul 2009 ... In this study, among those who were prescribed Regranex three or more times, there was an increase in the number of patients who died as a ...
http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInfo...

Effect of recombinant platelet-derived growth factor (Regranex) on ...
Here, we sought to determine the effectiveness of commercially sold PDGF-BB ( Regranex) on wound closure in genetically diabetic mice. ...
http://www.ncbi.nlm.nih.gov/pubmed/16566566...

Warning for Regranex—Cream for Leg and Foot Ulcers
28 Oct 2009 ... A boxed warning has been added to the label of Regranex Gel 0.01% (becaplermin) to address the increased risk of cancer death in patients ...
http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm048471.ht...

Becaplermin (Regranex) for Diabetic Foot Ulcers - July 15, 2008 ...
15 Jul 2008 ... Becaplermin (Regranex) topical gel is labeled for adjunctive treatment of stage III and IV diabetic neuropathic ulcers of the lower ...
http://www.aafp.org/afp/2008/0715/p255.html...

FDA Announces New Labeling Changes for Regranex
18 Jun 2009 ... The US Food and Drug Administration today announced the addition of a boxed warning to the label of Regranex Gel 0.01% (becaplermin) to ...
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/20...

The cost-effectiveness of treating diabetic lower extremity ulcers ...
The cost-effectiveness of treating diabetic lower extremity ulcers with becaplermin (Regranex): a core model with an application using Swedish cost data
. ...
http://www.ncbi.nlm.nih.gov/pubmed/16464208...

Regranex (becaplermin) Gel 0.01 % October 2008
11 Jul 2009 ... An increased rate of mortality secondary to malignancy was observed in patients treated with 3 or more tubes of Regranex Gel in a ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-...

Randomized clinical trial comparing OASIS Wound Matrix to Regranex ...
INTERVENTION: Patients were randomized to receive either OASIS Wound Matrix (n = 37) or Regranex Gel (n = 36) and a secondary dressing. ...
http://www.ncbi.nlm.nih.gov/pubmed/15942317...

Regranex (becaplermin) Gel
19 Jun 2009 ... [UPDATE 06/06/2008] FDA informed healthcare professionals that a Boxed Warning was added to prescribing information for Regranex that ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyA...

[Becaplermin gel (Regranex gel)]
Becaplermine gel (Regranex) is an hydrogel which contains 100 microg of Platelet Derived Growth Factor-BB (rhPDGF-BB) per gram. Regranex is presented in ...
http://www.ncbi.nlm.nih.gov/pubmed/15258509...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.